Activewear Brand AYBL Increases its Fulfillment Efficiency by 100% with Descartes’ Ecommerce Warehouse Management System 11-12-2023, 18:45

Telnyx builds momentum in Global Partner Motion 7-04-2025, 23:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00